TScan Therapeutics (TCRX)
(Delayed Data from NSDQ)
$8.98 USD
+0.08 (0.90%)
Updated May 17, 2024 04:00 PM ET
After-Market: $8.99 +0.01 (0.11%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/08/2024
Time: -- |
6/2024 | $-0.30 | 0.00% |
Earnings Summary
For their last quarter, TScan Therapeutics (TCRX) reported earnings of -$0.32 per share, missing the Zacks Consensus Estimate of -$0.25 per share. This reflects a negative earnings surprise of 28.00%. Look out for TCRX's next earnings release expected on August 08, 2024. For the next earning release, we expect the company to report earnings of -$0.30 per share, reflecting a year-over-year increase of 41.18%.
Earnings History
Price & Consensus
Zacks News for TCRX
AnaptysBio, Inc. (ANAB) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
TCRX: What are Zacks experts saying now?
Zacks Private Portfolio Services